{
  "cik": 1847367,
  "cik_padded": "0001847367",
  "entityName": "ALUMIS INC.",
  "fiscal_years": [
    {
      "accn": "0001847367-26-000006",
      "filed": "2026-03-19",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 17000.0,
        "capex": 653000.0,
        "cash": 89670000.0,
        "eps_diluted": -2.86,
        "free_cash_flow": -370176000.0,
        "net_income": -243325000.0,
        "operating_cash_flow": -369523000.0,
        "operating_income": -453804000.0,
        "revenue": 24050000.0,
        "stockholders_equity": 301297000.0,
        "total_assets": 411940000.0,
        "total_liabilities": 110643000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.36722237526427415,
        "roa_avg2y": -0.646339908517635,
        "roa_period_end": -0.5906806816526678,
        "roe_avg2y": -0.866849186232301,
        "roe_period_end": -0.807591844591881
      }
    },
    {
      "accn": "0001847367-26-000006",
      "filed": "2026-03-19",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 6000.0,
        "capex": 1732000.0,
        "cash": 169526000.0,
        "eps_diluted": -10.38,
        "free_cash_flow": -256810000.0,
        "net_income": -294233000.0,
        "operating_cash_flow": -255078000.0,
        "operating_income": -300754000.0,
        "stockholders_equity": 260104000.0,
        "total_assets": 340992000.0,
        "total_liabilities": 80888000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.31098329898809707,
        "roa_avg2y": -1.3666059767210708,
        "roa_period_end": -0.8628736158033035,
        "roe_avg2y": 7.434256405073525,
        "roe_period_end": -1.1312128994556023
      }
    },
    {
      "accn": "0001847367-26-000006",
      "filed": "2026-03-19",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 64000.0,
        "capex": 4499000.0,
        "cash": 45996000.0,
        "eps_diluted": -72.08,
        "free_cash_flow": -134474000.0,
        "net_income": -154993000.0,
        "operating_cash_flow": -129975000.0,
        "operating_income": -158174000.0,
        "stockholders_equity": -339260000.0,
        "total_assets": 89612000.0,
        "total_liabilities": 53502000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -1.7296009463018345,
        "roe_avg2y": 0.5799529281461996
      }
    },
    {
      "accn": "0001847367-25-000012",
      "filed": "2025-03-19",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -195242000.0
      },
      "period_end": "2022-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001847367-26-000006",
    "filed": "2026-03-19",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001847367.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001847367.json"
  },
  "ticker": "ALMS"
}